The majority of marijuana growers are occupied growing plants, while on the other hand, scientists at biotech firms are devotedly engineering what they consider to be a game-changer in the marijuana industry.It is synthetic cannabidiol made in the lab.
Since synthetic CBD has the potential to cut the vast charges of cultivating marijuana and hasten the Food and Drug Administration approval procedure, the mission has received backing from many companies, especially cannabis pharmaceutical firms aimed at manufacturing new drugs.Currently, scientists, universities, and some organizations are in the beginning stages of synthesizing hemp’s cannabidiol.
What is synthetic cannabidiol?
Synthetic CBD is not the same as synthetic marijuana. Synthetic marijuana is a misnomer that bears street labels such as Spice and K2 and is known for its “zombie” effect on the user. K2 is a criminalized mind-altering chemical substance sprayed on a mix of herbs and often smoked like cannabis. Illegitimate producers keep modifying the chemistry to evade the law.
Nonetheless, entrepreneurs are excited about the cleansed analogs of cannabidiol. This CBD has a more natural molecular build, making it easier to manufacture through organic chemistry in a medical lab. Cannabidiol is among the dozens of cannabinoids found in marijuana. Another famously-known cannabinoid is tetrahydrocannabinol (THC), which acts as a psychoactive compound giving users a “high” sensation.
CBD has gained favor among the public because of its healing capabilities and non-psychoactive nature. According to New Frontier Data, the CBD industry is likely to make more than 1.3 billion USD in sales by 2022. Previous records show sales immensely rising to 367 million USD between 2014 and 2017.
How far are we from developing lab CDB?
Unlike cannabidiol, tetrahydrocannabinol has previously been synthesized for pharmaceutical applications in sporadic unique cases. Because of this synthesizing of marijuana compounds, you should make sure to get your cannabis products from reputable traders like berkshirecbd.com. Marinol and Syndros are the two known drugs to contain lab-engineered THC as an ingredient.
The compound known as dronabinol was authorized by the food and administration board back in 1985. The medicine is mostly used to help patients with nausea caused by chemo or AIDS patients. Another drug, Cesamet, which is also used by chemo patients, contains a varying synthetic that bears the same structure as THC.
With cannabidiol, the rate has been slower. However, in June 2018, the FDA allowed the first drug made with CDB, Epidiolex. The drug is used in treating kids with serious forms of epilepsy. According to the vice president of investor relation, GW Pharmaceuticals, the company that manufactured the drug, the cannabidiol in Epidiolex is extracted from the plant.
When doing a background check on other drugs, synthesizing is probably the best method as far as medical advancement is concerned. For instance, instead of people eating mold when they have pneumonia, they get a prescription for penicillin. Penicillin was synthesized and mass-manufactured during the second world war.
Where is the opportunity?
Pharmaceutical and biotech firms are witnessing billion-dollar signals. Some firms are already manufacturing CBD using yeast. Biotechs such a Katexcio Pharmaceutical are focusing on creating their synthetic versions of medical-grade cannabidiol. The firms aim at harnessing CBD properties along with different compounds to assist in making drugs for treating rheumatoid arthritis, multiple sclerosis, and other inflammatory disorders.
The drugs would undergo clinical testing and were later handed to the FDA for approval. There is also the chance to patent the methods used in manufacturing synthesized CBD, more specifically the biosynthesis of the particle.
Throughout the market, CBD manufactured in the lab could be more affordable and accessible to mass manufacture than that extracted from the hemp plant. Another benefit for firms in the pharmaceutical sector is synthetic CBD will make it easier to get approval from the FDA. Who knows, maybe synthetic CBD is the future.